Drugs / ABBV-303
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06158958 | Feb 2024 → Oct 2025 | cancer | AbbVie | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABBV-303 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06158958 ↗ |
| Route | Intravenous | “Intravenous (IV) Infusion” NCT06158958 ↗ |